Infectious Disease Diagnostics Market Trends, Size, Segments, Emerging Technologies 2027

1
Infectious Disease Diagnostics Market Challenges,
Size, Growth, Key Vendors, Drivers till 2027

• Published Date May 2022

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com

• Infectious Disease Diagnostics Market Forecast to
  2028- COVID-19 Impact, and Global Analysis - by
  Product (Kits and Reagents, Instruments, and
  Software and Service  ss), Disease Indication
  HIV, Hepatitis, Healthcare- Associated
  Infections (HAIs), Human Papillomavirus (HPV),
  Tuberculosis (TB), Influenza, and Others Disease
  Indications  , Technology (Immunodiagnostics,
  Polymerase Chain Reaction, Next Generation
  Sequencing, Clinical Microbiology, and Others),
  Testing Type (Laboratory Testing and, Point of
  Care Testing), End User (Hospitals and Clinics,
  Pathology or Diagnostic Laboratories, Research
  Institutes, Home-Care Settings, and Others End
  User), and Geography

3
Infectious Disease Diagnostics Market Overview
Email sales_at_theinsightpartners.com

• The Infectious Disease Diagnostics Market is
  expected to grow from US 23,890 million in 2021
  to US 37,943.90 million by 2028 it is estimated
  to grow at a CAGR of 6.8 from 2021 to 2028
• The report highlights the major factors driving
  the market and prominent players and their
  developments. The growth of the global infectious
  disease diagnostic market is majorly driven by an
  increase in the prevalence of infectious
  diseases, including hepatitis, influenza,
  COVID-19, and human immunodeficiency virus (HIV)
  a rise in demand for point-of-care diagnostic
  tests a surge in funding from private
  government organizations for diagnostic service
  centers and advancements in technologies in the
  field of infectious disease diagnostics. However,
  the high cost associated with diagnostic
  instruments and the lack of skilled technicians
  in the global market is hampering the market
  growth.

4
Key Segment Market
Email sales_at_theinsightpartners.com

• Segment By Type-
• Disease Indication-Based (HIV, hepatitis,
  healthcare- associated infections (HAIs), human
  papillomavirus (HPV), tuberculosis (TB),
  influenza, and others)
• Technology-Based  (Immunodiagnostics, Polymerase
  Chain Reaction, Next Generation Sequencing,
  Clinical Microbiology, And Others)
• End-User (Hospitals Clinics, Pathology Or
  Diagnostic Laboratories, Research Institutes,
  Home Care Settings, And Others)

Download Sample
5
Infectious Disease Diagnostics Market Value
Email sales_at_theinsightpartners.com

• CAGR of 6.1
• (2021 - 2028)

Download Sample
6
Company Profiles
Email sales_at_theinsightpartners.com

• Danaher
• Abbott
• BD
• Trinity Biotech
• F. HOFFMANN-LA ROCHE LTD.
• Cardinal Health Inc.
• BioMerieux SA
• BIO-RAD LABORATORIES INC.
• AccuBioTech Co. Ltd.
• ACON Laboratories, Inc.

Download Sample
7
By Geography
Email sales_at_theinsightpartners.com

• North America (the US, Canada, and Mexico)
• Europe (the UK, Germany, France, Italy, Spain,
  and the Rest of Europe)
• Asia Pacific (China, Japan, India, Australia,
  South Korea, and the Rest of Asia Pacific)
• Middle East Africa (the UAE, Saudi Arabia,
  South Africa, and the Rest of Middle East
  Africa)
• South Central America (Brazil, Argentina, and
  the Rest of South Central America).

8
THANKYOU!

• Phone  [phone]

• E-Mail sales_at_theinsightpartners.com